Krajina: Nový Zéland
Jazyk: angličtina
Zdroj: Medsafe (Medicines Safety Authority)
Docetaxel 10 mg/mL
Novartis New Zealand Ltd
Docetaxel 10 mg/mL
80 mg/8mL
Concentrate for infusion
Active: Docetaxel 10 mg/mL Excipient: Citric acid Ethanol Nitrogen Polysorbate 80
Vial, glass, with latex-free rubber stopper & flip-off aluminium crimp, 8 mL
Prescription
Prescription
Sicor de Mexico SA de CV
Metastatic Breast Cancer Docetaxel Sandoz is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel Sandoz in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.
Package - Contents - Shelf Life: Vial, glass, with latex-free rubber stopper & flip-off aluminium crimp - 8 mL - 24 months from date of manufacture stored at or below 25°C 48 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)
2012-09-17
Docetaxel Sandoz 1 DOCETAXEL SANDOZ _ _ DOCETAXEL CONCENTRATED INJECTION FOR INFUSION _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Docetaxel Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT DOCETAXEL SANDOZ IS USED FOR The name of the medicine is called Docetaxel Sandoz. It contains the active ingredient docetaxel. Docetaxel belongs to a group of medicines called antineoplastic or cytotoxic medicines. These may also be called chemotherapy medicines. It works by killing cancer cells and stopping cancer cells from growing and multiplying. This medicine is used to treat _ _ breast cancer_ _ ovarian cancer_ _ some types of lung cancer_ _ head and neck cancer_ _ prostate cancer._ _ ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed Docetaxel Sandoz for another reason. Docetaxel Sandoz may be used alone or in combination with other medicines to treat cancer. This medicine is not addictive. This medicine is available only with a doctor’s prescription. There is not enough information to recommend the use of this medicine for children. Docetaxel Sandoz 2 BEFORE YOU ARE GIVEN DOCETAXEL SANDOZ _WHEN YOU MUST NOT BE GIV Prečítajte si celý dokument
_New Zealand Data Sheet_ Page 1 of 39 _Docetaxel Sandoz 20mg/2ml & 80mg/8ml concentrated injection for infusion _ _ 12/2014_ _Sandoz Pty Ltd _ _ _ _ _ DATA SHEET DOCETAXEL SANDOZ ® 20MG/2ML& 80MG/8ML CONCENTRATEDINJECTION FOR INFUSION NAME OF THE MEDICINE _ _ Generic name: Docetaxel Chemical name: 1,7β, 10β-Trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4- acetate 2-benzoate 13-[(2_R_,3_S_)-3-[[(1,1- dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] CAS: 114977-28-5 Empirical formula: C 43 H 53 NO 14 MW: 807.88 DESCRIPTION Docetaxel is a white to almost white powder. It is highly lipophilic and practically insoluble in water. The concentrated injection for infusion is a sterile clear, colourless to pale yellow solution free from visible particulates. Docetaxel SandozConcentrated Injection for Infusion Single-dose vials of Docetaxel Sandoz concentratedinjection for infusion contain either 20mg or 80mg of docetaxel, in 2.0mL or 8.0mL of solvent, respectively. The sterile pyrogen-free viscous solution contains a concentration of 10mg/mL docetaxel. Each mL of Docetaxel Sandoz concentrated injection for infusion contains the inactive ingredients ethanol590.85mg, polysorbate 80 268.25mgand citric acid, anhydrous 1mg. _New Zealand Data Sheet_ Page 2 of 39 _Docetaxel Sandoz 20mg/2ml & 80mg/8ml concentrated injection for infusion _ _ 12/2014_ _Sandoz Pty Ltd _ _ _ _ _ PHARMACOLOGY Approval of Docetaxel Sandoz in New Zealand is on the basis of its chemical similarity to the New Zealand innovator product. Docetaxel is an antineoplastic agent which acts by promoting the assembly of tubulin into stablemicrotubules and inhibits their disassembly which leads to a marked decrease of free tubulin. Thebinding of docetaxel to microtubules does not alter the number of protofilaments.Docetaxel has been shown _in vitro _to disrupt the microtubular network in cells which is essential for vital mitotic and interphase cellular functions. Pharmacodynamics Docetaxel was found to be cytotoxic _in vitro _against vario Prečítajte si celý dokument